These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38049508)

  • 21. Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis.
    Mato AR; Nabhan C; Thompson MC; Lamanna N; Brander DM; Hill B; Howlett C; Skarbnik A; Cheson BD; Zent C; Pu J; Kiselev P; Goy A; Claxton D; Isaac K; Kennard KH; Timlin C; Landsburg D; Winter A; Nasta SD; Bachow SH; Schuster SJ; Dorsey C; Svoboda J; Barr P; Ujjani CS
    Haematologica; 2018 May; 103(5):874-879. PubMed ID: 29419429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: A clinical clue to a different mechanism of pathogenesis?
    Bloom R; Amber KT; Nouri K
    Australas J Dermatol; 2016 Aug; 57(3):e114-6. PubMed ID: 25801041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
    Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Tsimberidou AM; Wen S; McLaughlin P; O'Brien S; Wierda WG; Lerner S; Strom S; Freireich EJ; Medeiros LJ; Kantarjian HM; Keating MJ
    J Clin Oncol; 2009 Feb; 27(6):904-10. PubMed ID: 19114699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upper aerodigestive tract cancer in patients with chronic lymphocytic leukemia: incidence, stage, and outcome.
    Pagedar NA; Halfdanarson TR; Karnell LH; Hoffman HT; Funk GF
    Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1171-5. PubMed ID: 23247237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program.
    Abel GA; Bertrand KA; Earle CC; Laden F
    Hematol Oncol; 2010 Sep; 28(3):133-6. PubMed ID: 19866451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study.
    Brewer JD; Shanafelt TD; Otley CC; Roenigk RK; Cerhan JR; Kay NE; Weaver AL; Call TG
    J Clin Oncol; 2012 Mar; 30(8):843-9. PubMed ID: 22331952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study.
    Kabadi SM; Near A; Wada K; Burudpakdee C
    Adv Ther; 2020 Jul; 37(7):3129-3148. PubMed ID: 32399812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.
    Cuneo A; Mato AR; Rigolin GM; Piciocchi A; Gentile M; Laurenti L; Allan JN; Pagel JM; Brander DM; Hill BT; Winter A; Lamanna N; Tam CS; Jacobs R; Lansigan F; Barr PM; Shadman M; Skarbnik AP; Pu JJ; Sehgal AR; Schuster SJ; Shah NN; Ujjani CS; Roeker L; Orlandi EM; Billio A; Trentin L; Spacek M; Marchetti M; Tedeschi A; Ilariucci F; Gaidano G; Doubek M; Farina L; Molica S; Di Raimondo F; Coscia M; Mauro FR; de la Serna J; Medina Perez A; Ferrarini I; Cimino G; Cavallari M; Cucci R; Vignetti M; Foà R; Ghia P;
    Cancer Med; 2020 Nov; 9(22):8468-8479. PubMed ID: 32969597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
    Kumar V; Ailawadhi S; Bojanini L; Mehta A; Biswas S; Sher T; Roy V; Vishnu P; Marin-Acevedo J; Alegria VR; Paulus A; Aulakh S; Iqbal M; Manochakian R; Tan W; Chanan-Khan A; Ailawadhi M
    Blood Cancer J; 2019 Sep; 9(10):75. PubMed ID: 31570695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
    Robertson LE; Estey E; Kantarjian H; Koller C; O'Brien S; Brown B; Keating MJ
    Leukemia; 1994 Dec; 8(12):2047-51. PubMed ID: 7807993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States.
    Shah UA; Shah N; Qiao B; Acuna-Villaorduna A; Pradhan K; Adrianzen Herrera D; Sica RA; Shastri A; Mantzaris I; Derman O; Kornblum N; Braunschweig I; Ye BH; Verma A; Janakiram M
    Cancer; 2020 Feb; 126(3):567-574. PubMed ID: 31769871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y; Wang Y; Wang Z; Yi D; Ma S
    Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
    Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
    Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An examination of the sensitivity of reported trends in childhood leukemia incidence rates to geographic location and diagnostic coding (United States).
    Liberson GL; Golden RJ; Blot WJ; Fisch H; Watson C
    Cancer Causes Control; 2000 May; 11(5):413-7. PubMed ID: 10877334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
    Mato AR; Thompson M; Allan JN; Brander DM; Pagel JM; Ujjani CS; Hill BT; Lamanna N; Lansigan F; Jacobs R; Shadman M; Skarbnik AP; Pu JJ; Barr PM; Sehgal AR; Cheson BD; Zent CS; Tuncer HH; Schuster SJ; Pickens PV; Shah NN; Goy A; Winter AM; Garcia C; Kennard K; Isaac K; Dorsey C; Gashonia LM; Singavi AK; Roeker LE; Zelenetz A; Williams A; Howlett C; Weissbrot H; Ali N; Khajavian S; Sitlinger A; Tranchito E; Rhodes J; Felsenfeld J; Bailey N; Patel B; Burns TF; Yacur M; Malhotra M; Svoboda J; Furman RR; Nabhan C
    Haematologica; 2018 Sep; 103(9):1511-1517. PubMed ID: 29880613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period.
    Utuama O; Mukhtar F; Pham YT; Dabo B; Manani P; Moser J; Michael-Asalu A; Tran CT; Le LC; Le TV; Vu KT; Park JY; Boffetta P; Zheng W; Shu XO; Luu HN
    PLoS One; 2019; 14(8):e0220864. PubMed ID: 31425527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro.
    Weiler S; Ademokun JA; Norton JD
    Mol Cancer; 2015 Feb; 14(1):30. PubMed ID: 25644253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.